| Kodiak Sciences Inc | 533K | US$50.5M | 5.1% |
| Abivax SA | 286K | US$28.4M | 2.9% |
| Vaxcyte, Inc. | 400K | US$22.8M | 2.3% |
| Arcus Biosciences, Inc. | 735K | US$19M | 1.9% |
| Celldex Therapeutics, Inc. | 519K | US$16.8M | 1.7% |
| Amylyx Pharmaceuticals, Inc. | 561K | US$16.3M | 1.6% |
| Vera Therapeutics, Inc. | 400K | US$12.9M | 1.3% |
| Alto Neuroscience, Inc. | 482K | US$12.3M | 1.2% |
| Cogent Biosciences, Inc. | 370K | US$11.9M | 1.2% |
| ANI Pharmaceuticals, Inc. | 149K | US$10.8M | 1.1% |
| Enliven Therapeutics, Inc. | 232K | US$10.6M | 1.1% |
| Maze Therapeutics, Inc. | 301K | US$8.19M | 0.82% |
| Contineum Therapeutics, Inc. | 595K | US$7.98M | 0.80% |
| Cue Biopharma, Inc. | 291K | US$7.52M | 0.76% |
| Eupraxia Pharmaceuticals, Inc. | 810K | US$7.37M | 0.74% |
| Tectonic Therapeutic, Inc. | 306K | US$7.13M | 0.72% |
| ORIC Pharmaceuticals, Inc. | 523K | US$7.04M | 0.71% |
| Monopar Therapeutics Inc. | 86,761 | US$6.91M | 0.70% |
| C4 Therapeutics, Inc. | 1.93M | US$6.44M | 0.65% |
| Alpha Cognition Inc. | 701K | US$6.31M | 0.63% |
| Immunome, Inc. | 285K | US$6.13M | 0.62% |
| Jade Biosciences, Inc. | 427K | US$6M | 0.60% |
| Cybin, Inc. | 488K | US$5.99M | 0.60% |
| Sensei Biotherapeutics, Inc. | 200K | US$5.94M | 0.60% |
| Freenome, Inc. | 363K | US$5.71M | 0.57% |
| Cardiol Therapeutics Inc. Class A | 3.33M | US$5.52M | 0.56% |
| Relmada Therapeutics, Inc. | 1.45M | US$5.46M | 0.55% |
| Pelthos Therapeutics Inc. | 257K | US$5.39M | 0.54% |
| Ovid Therapeutics Inc. | 2.12M | US$5.28M | 0.53% |
| Spruce Biosciences, Inc. | 101K | US$4.92M | 0.50% |
| Vor Biopharma Inc. | 250K | US$4.77M | 0.48% |
| Vogenx Inc | 209K | US$4.76M | 0.48% |
| Viridian Therapeutics, Inc. | 225K | US$4.63M | 0.47% |
| Bright Minds Biosciences Inc. | 88,951 | US$4.43M | 0.45% |
| Zura Bio Limited | 1.02M | US$4.24M | 0.43% |
| Inventiva SA | 1.13M | US$4.22M | 0.42% |
| Cumberland Pharmaceuticals Inc. | 503K | US$3.94M | 0.40% |
| Septerna, Inc. | 100K | US$3.91M | 0.39% |
| Rezolute, Inc. | 935K | US$3.87M | 0.39% |
| Amanat Acquisition Corp | 350K | US$3.73M | 0.37% |
| CAMP4 Therapeutics Corporation | 913K | US$3.69M | 0.37% |
| Ocugen, Inc. | 3.56M | US$3.67M | 0.37% |
| Alector, Inc. | 1.98M | US$3.67M | 0.37% |
| Olema Pharmaceuticals, Inc. | 383K | US$3.31M | 0.33% |
| Silence Therapeutics PLC | 822K | US$3.29M | 0.33% |
| Ginkgo Bioworks Holdings, Inc. | 250K | US$3.21M | 0.32% |
| Q32 Bio Inc. | 345K | US$2.85M | 0.29% |
| Arvinas, Inc. | 358K | US$2.77M | 0.28% |
| Connect Biopharma Holdings Limited | 2.24M | US$2.46M | 0.25% |
| Rein Therapeutics, Inc. | 2.95M | US$2.37M | 0.24% |
| Kazia Therapeutics Ltd | 246K | US$2.36M | 0.24% |
| Acumen Pharmaceuticals, Inc. | 1.05M | US$2.34M | 0.24% |
| Invivyd, Inc. | 2.66M | US$2.31M | 0.23% |
| ACADIA Pharmaceuticals Inc. | 112K | US$2.26M | 0.23% |
| ProMIS Neurosciences Inc. | 205K | US$2.22M | 0.22% |
| Crescent Biopharma, Inc. | 150K | US$2.19M | 0.22% |
| Obsidian Therapeutics, Inc. | 159K | US$2.18M | 0.22% |
| Capricor Therapeutics, Inc. | 229K | US$2.17M | 0.22% |
| Delcath Systems, Inc. | 136K | US$2.17M | 0.22% |
| 4D Molecular Therapeutics, Inc. | 150K | US$2.15M | 0.22% |
| Praxis Precision Medicines, Inc. | 6,942 | US$2.02M | 0.20% |
| Neuronetics, Inc. | 810K | US$1.9M | 0.19% |
| Biohaven Ltd. | 133K | US$1.78M | 0.18% |
| Lexeo Therapeutics, Inc. | 513K | US$1.73M | 0.17% |
| Verastem, Inc. | 214K | US$1.72M | 0.17% |
| Journey Medical Corporation | 251K | US$1.72M | 0.17% |
| Immunic, Inc. | 182K | US$1.7M | 0.17% |
| PepGen Inc. | 694K | US$1.68M | 0.17% |
| Fulcrum Therapeutics, Inc. | 449K | US$1.66M | 0.17% |
| Tyra Biosciences, Inc. | 65,000 | US$1.42M | 0.14% |
| Avalo Therapeutics, Inc. | 90,183 | US$1.38M | 0.14% |
| Cabaletta Bio, Inc. | 700K | US$1.34M | 0.14% |
| Tarsus Pharmaceuticals, Inc. | 16,858 | US$1.33M | 0.13% |
| Palatin Technologies, Inc. | 130K | US$1.15M | 0.12% |
| iBio, Inc. | 957K | US$1.13M | 0.11% |
| Lipocine Inc. | 509K | US$1.12M | 0.11% |
| Pliant Therapeutics, Inc. | 1M | US$1.08M | 0.11% |
| DBV Technologies SA | 453K | US$1.07M | 0.11% |
| Harrow, Inc. | 33,275 | US$1.02M | 0.10% |
| Quoin Pharmaceuticals. Ltd | 212K | US$965K | 0.10% |
| Jasper Therapeutics, Inc. | 1.34M | US$779K | 0.08% |
| Neumora Therapeutics, Inc. | 1.28M | US$762K | 0.08% |
| CNS Pharmaceuticals, Inc. | 136K | US$720K | 0.07% |
| Kalaris Therapeutics, Inc. | 248K | US$717K | 0.07% |
| EyePoint, Inc. | 205K | US$671K | 0.07% |
| AEON Biopharma, Inc. | 2.2M | US$661K | 0.07% |
| TCGX Acquisition Corp. | 50,000 | US$626K | 0.06% |
| Fractyl Health, Inc. | 1.1M | US$599K | 0.06% |
| Foghorn Therapeutics Inc. | 160K | US$571K | 0.06% |
| Adlai Nortye Group Ltd. | 33,899 | US$542K | 0.05% |
| Palisade Bio, Inc. | 400K | US$540K | 0.05% |
| Equillium, Inc. | 304K | US$493K | 0.05% |
| Sionna Therapeutics, Inc. | 85,300 | US$449K | 0.05% |
| Lyell Immunopharma, Inc. | 41,081 | US$402K | 0.04% |
| Anteris Technologies Global Corp. | 50,862 | US$395K | 0.04% |
| Hyperliquid Strategies Inc | 30,001 | US$368K | 0.04% |
| Viking Therapeutics, Inc. | 9,717 | US$317K | 0.03% |
| Solid Biosciences Inc. | 42,956 | US$311K | 0.03% |
| Lexicon Pharmaceuticals, Inc. | 165K | US$309K | 0.03% |
| Alumis Inc. | 41,177 | US$304K | 0.03% |